(Q35951733)

English

Thymalfasin: an immune system enhancer for the treatment of liver disease

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

title

Thymalfasin: an immune system enhancer for the treatment of liver disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 August 2017

Maria H Sjogren

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

publication date

1 December 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

published in

Journal of Gastroenterology and Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

volume

19 Suppl 6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

page(s)

S69-72

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

cites work

Thymosin-alpha1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03635.X

retrieved

21 January 2018

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03635.X

retrieved

21 January 2018

Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis f

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03635.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1440-1746.2004.03635.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

PubMed publication ID

15546253

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15546253

retrieved

11 August 2017

15641207

reason for deprecated rank

unchecked identifier

0 references

(Q35951733)

Thymalfasin: an immune system enhancer for the treatment of liver disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)